RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2116
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:128
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

RXi Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by RXi Pharmaceuticals Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes RXi Pharmaceuticals Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by RXi Pharmaceuticals Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on RXi Pharmaceuticals Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by RXi Pharmaceuticals Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for RXi Pharmaceuticals Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about RXi Pharmaceuticals Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 16
Partnership – Overview 16
Partnership – Deal reports 17
CAPITAL RAISING 78
Capital Raising – Overview 78
Capital Raising – Deal reports 79
DIVESTMENTS 108
Divestments – Overview 108
Divestments – Deal reports 109
PRIVATE EQUITY & OWNERSHIP 113
Private Equity and Ownership – Deal reports 113
APPENDIX 118
Contact Us 118
About MarketLine Financial Deals Database 118
Deal Definition and Methodology 120
About MarketLine 127

List of Tables
Table 1: RXi Pharmaceuticals Corporation M&A volume and value trend (2014-YTD2018)
Table 2: RXi Pharmaceuticals Corporation M&A activity by geography (2014-YTD2018)
Table 3: RXi Pharmaceuticals Corporation partnership volume and value trend (2014-YTD2018)
Table 4: RXi Pharmaceuticals Corporation partnership trend by key deal type (2014-YTD2018)
Table 5: RXi Pharmaceuticals Corporation capital raising volume and value trend (2014-YTD2018)
Table 6: RXi Pharmaceuticals Corporation capital raising by deal type (2014-YTD2018)
Table 7: RXi Pharmaceuticals Corporation divestments volume and value trend (2014-YTD2018)
Table 8: RXi Pharmaceuticals Corporation divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: RXi Pharmaceuticals Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: RXi Pharmaceuticals Corporation M&A activity by geography (2014-YTD2018)
Figure 3: RXi Pharmaceuticals Corporation partnership volume and value trend (2014-YTD2018)
Figure 4: RXi Pharmaceuticals Corporation partnership trend by key deal type (2014-YTD2018)
Figure 5: RXi Pharmaceuticals Corporation capital raising volume and value trend (2014-YTD2018)
Figure 6: RXi Pharmaceuticals Corporation capital raising by deal type (2014-YTD2018)
Figure 7: RXi Pharmaceuticals Corporation divestments volume and value trend (2014-YTD2018)
Figure 8: RXi Pharmaceuticals Corporation divestments by geography (2014-YTD2018)

★海外企業調査レポート[RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cap Gemini S.A.:戦略・SWOT・企業財務分析
    Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report Summary Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tivity Health Inc (TVTY):企業の財務・戦略的SWOT分析
    Tivity Health Inc (TVTY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Carl Zeiss Meditec Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec Inc (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a medical technology company that manufactures and markets various healthcare products. The company provides ophthalmology and optometry products, neurosurgery products, ENT products, spine surgery products …
  • IXICO Plc (IXI):医療機器:M&Aディール及び事業提携情報
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as assessa, trial tracker, trialwire and mehealth. It provides web-based …
  • Program for Appropriate Technology in Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …
  • Duke Energy Corporation (DUK):石油・ガス:M&Aディール及び事業提携情報
    Summary Duke Energy Corp (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also procures …
  • Cimentos de Portugal SGPS SA:企業の戦略的SWOT分析
    Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Cedar Fair, L.P.:企業の戦略・SWOT・財務情報
    Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report Summary Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Zynex Inc (ZYXI):医療機器:M&Aディール及び事業提携情報
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • Medherant Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Chiesi USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiesi USA Inc (Chiesi USA), a specialty pharmaceutical company, is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company researches, develops, produces and commercializes innovative products in the areas such as cardiovascular, respiratory, neonatology, rare disease and specia …
  • BCE Inc.:企業の戦略・SWOT・財務情報
    BCE Inc. - Strategy, SWOT and Corporate Finance Report Summary BCE Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Bone Biologics Corp (BBLG):医療機器:M&Aディール及び事業提携情報
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also …
  • Aragen Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc, is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process d …
  • Yanlord Land Group Ltd
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SNGN Romgaz SA (SNG):企業の財務・戦略的SWOT分析
    Summary SNGN Romgaz SA (Romgaz) is an oil and gas company which explores produces and supplies natural gas. The company's activities include exploration of petroleum onshore and offshore, natural gas production, electric power production, trading and technological transport. Romgaz through its well …
  • Nan Ya Plastics Corp (1303):企業の財務・戦略的SWOT分析
    Nan Ya Plastics Corp (1303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Symphogen AS:企業の戦略的SWOT分析
    Symphogen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Wolverine World Wide, Inc.:企業の戦略・SWOT・財務情報
    Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Universal Electronics Inc (UEIC):企業の財務・戦略的SWOT分析
    Summary Universal Electronics Inc (Universal Electronics) is a technology company that offers control and sensor technology solutions. The company offers a range of pre-programmed and universal remote control products, audio-video accessories, intelligent wireless security and automation components, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆